APA (7th ed.) Citation

Moniot, A., Schneider, C., Chardin, L., Yaniz-Galende, E., Genestie, C., Etiennot, M., . . . Dubot, C. (2024). The CD47/TSP-1 axis: A promising avenue for ovarian cancer treatment and biomarker research. Molecular Cancer, 23(1), 1. https://doi.org/10.1186/s12943-024-02073-0

Chicago Style (17th ed.) Citation

Moniot, Aurélie, et al. "The CD47/TSP-1 Axis: A Promising Avenue for Ovarian Cancer Treatment and Biomarker Research." Molecular Cancer 23, no. 1 (2024): 1. https://doi.org/10.1186/s12943-024-02073-0.

MLA (9th ed.) Citation

Moniot, Aurélie, et al. "The CD47/TSP-1 Axis: A Promising Avenue for Ovarian Cancer Treatment and Biomarker Research." Molecular Cancer, vol. 23, no. 1, 2024, p. 1, https://doi.org/10.1186/s12943-024-02073-0.